Tuesday, November 24, 2009

Asthma Home>
Asthma News>
Asthma drugs get 'precaution' labeling

Font size
- A
- A
- A
Email This

Bookmark

Save

Are you an asthma suffer? Manage your asthma or COPD with great ideas from people like you.Start here.

Asthma drugs get 'precaution' labeling

(Boston Globe) UPDATED 2009-06-16

The U.S. Food and Drug Administration (FDA) has requested that asthma drugs in the leukotriene receptor agonists category be given a "precaution" on the drugs' label. The drugs--which include Singulair, Accolate, and Zyflo--have garnered some complaints from patients regarding psychiatric side effects including insomnia, depression, agitation, and suicidal ideation. Safety reviews into the meds are ongoing, but in the meantime the FDA says patients and doctors should be aware of the risk of neuropsychiatric events associated with the medications. Read full story >

See all Asthma News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyAsthmaCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.